Inactive Instrument

Calmare Therapeutics Incorporated

Equities

CTTC

US13126R1023

Advanced Medical Equipment & Technology

Competitive Technologies Inc. Names Carl O'Connell as President and Chief Executive Officer

October 31, 2012 at 06:56 pm

Competitive Technologies Inc. announced that its Board of Directors has named Carl O'Connell as President and Chief Executive Officer. Mr. O'Connell replaces Johnnie D. Johnson, interim Chief Executive Officer, who will continue serving as Chief Financial Officer and Director of Investor Relations reporting to Mr. O'Connell. The appointments take effect November 1, 2012.

Prior to joining Competitive Technologies Mr. O'Connell held executive positions for top global medical device and fortune 500 companies. He recently served as President and CEO for the US Healthcare Division MedSurg for ITOCHU.

Latest news about Calmare Therapeutics Incorporated

Calmare Therapeutics Incorporated Wins $2.5 Million Federal Supply Schedule Contract	09/06/20	CI
Calmare Therapeutics Incorporated Announces Board Changes	19/07/19	CI
Carl O'connell to Resign as Member of the Board of Directors of Calmare Therapeutics Incorporation, Effective on or About June 26, 2019	12/06/19	CI
Declaration of Voting Results by Calmare Therapeutics	02/07/18	CI
Calmare Therapeutics Declares Preliminary Tally of Consents by Shareholders	15/06/18	CI
Calmare Therapeutics Solicits Proxies from Shareholders	16/01/18	CI
Calmare Therapeutics Solicits Proxies from Shareholders	12/01/18	CI
Calmare Therapeutics Solicits Proxies from Shareholders	02/01/18	CI
Stanley Yarbro Solicits Proxies from Shareholders of Calmare Therapeutics	08/12/17	CI
Stanley Yarbro Solicits Proxies from Shareholders of Calmare Therapeutics	04/12/17	CI
Stanley Yarbro Solicits Proxies from Shareholders of Calmare Therapeutics	22/11/17	CI
Stanley Yarbro Sends Letter to Board of Directors of Calmare Therapeutics	21/09/17	CI
Stanley Yarbro Sends Director Nomination Notice to Calmare Therapeutics	21/09/17	CI
Stanley Yarbro Threatens Calmare Therapeutics with Legal Action	21/09/17	CI
Calmare Therapeutics Incorporated Auditor Raises 'Going Concern' Doubt	20/07/17	CI
Stanley Yarbro Sends Letter to Calmare Therapeutics	30/06/17	CI
Calmare Therapeutics, Inc. Removes Stan Yarbro as Director	23/03/17	CI
Calmare Therapeutics Incorporated Resignation of Robert T. Conway and Steve Roehrich from the Board	23/02/17	CI
Calmare Therapeutics Incorporated cancelled the transaction announced on September 10, 2013	09/09/16	CI
Calmare Therapeutics Incorporated Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2016	19/05/16	CI
Calmare Therapeutics Incorporated Receives Final Signatures on Supply Order Contract Documents	05/05/16	CI
Calmare Therapeutics Incorporated Auditor Raises 'Going Concern' Doubt	13/04/16	CI
Calmare Therapeutics Incorporated Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2015	02/03/16	CI
Calmare Therapeutics Incorporated Wins $15 Million General Supply Order Contract	18/02/16	CI
Calmare Therapeutics Incorporated Appoints Christine Chansky, M.D., J.D., F.C.L.M., as a Chief Regulatory Officer	17/02/16	CI

Chart Calmare Therapeutics Incorporated

Duration

Period

More charts

Company Profile

Calmare Therapeutics Incorporated is a biotherapeutic company. The Company's medical devices offer a non-pharmacological (no drugs), non-addictive (no narcotics) and non-invasive (over the skin) solution to chronic pain sufferers in an outpatient treatment setting. It supplements its medical devices with a catalog of private label neurostimulation and sensory electrodes. Its flagship medical device, the Calmare Pain Therapy Device is a non-invasive and non-addictive modality that treats chronic and neuropathic pain. Its devices are commercially sold to medical practices throughout the world. Its technology portfolio includes PMT 1, Neuroprotection and Cognitive Enhancement, Sexual Dysfunction Therapeutic, Skin Pigment Enhancer and Wound Sealant. The Company's clients include universities, corporations, and inventors.

Sector

Advanced Medical Equipment & Technology

More about the company

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
THERMO FISHER SCIENTIFIC	+7.01%	217B
DANAHER CORPORATION	+11.01%	190B
INTUITIVE SURGICAL, INC.	+19.20%	143B
BOSTON SCIENTIFIC CORPORATION	+30.79%	111B
SIEMENS HEALTHINEERS AG	+1.48%	64.59B
EDWARDS LIFESCIENCES CORPORATION	+13.95%	52.36B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.16%	48.45B
AGILENT TECHNOLOGIES, INC.	-6.20%	38.03B
GE HEALTHCARE TECHNOLOGIES INC.	+0.91%	35.6B

Other Advanced Medical Equipment & Technology